[SGMO] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
12-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 129.54%
YoY- 110.25%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 49,412 9,398 26,460 28,563 57,763 21,958 23,562 13.12%
PBT 10,760 -102,893 -53,125 -47,602 -1,271 -27,361 -12,843 -
Tax 88 1,270 30 86 237 -54 0 -
NP 10,672 -104,163 -53,155 -47,688 -1,550 -27,307 -12,843 -
Tax Rate -0.82% - - - - - - -
Total Cost 38,740 113,561 79,615 76,251 59,313 49,265 36,405 1.04%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 21.60 -1,108.35 -200.89 -166.96 -2.68 -124.36 -54.51 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS 0.05 -0.59 -0.34 -0.33 -0.01 -0.24 -0.13 -
EPS Diluted 0.05 -0.59 -0.34 -0.33 -0.01 -0.24 -0.13 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.